Silo thinking can significantly hamper efficient drug development. We know that close communication between experts in formulation development and clinical trials can bring significant advantages to Phase I and bioequivalence studies.
For many customers it is advantageous to purchase the manufacture of clinical trial material (CTM), the trial itself, bioanalysis and study reporting services from the same supplier. For this reason we offer Phase I and bioequivalence studies, complete with CTM and bioanalysis as a package, together with CTC Clinical Trial Consultants.
As a result, you can agree a time plan and cost with one party and we will take care of all coordination. If you want to use another clinical lab and just access CTM and/or bioanalysis services from us that is also possible. We can be involved as much or as little as you need.